Show simple item record

dc.contributor.authorNaziru, Rashid
dc.date.accessioned2022-05-16T07:32:33Z
dc.date.available2022-05-16T07:32:33Z
dc.date.issued2022-02-28
dc.identifier.citationNAZIRU,S.(2022).SARS-COV-2 B.1.1.529 (OMICRON) VARIANT OUTBREAK:CASE SERIES PRESENTATIONS AND RESPONSE TO TREATMENT AT THE ISLAMIC UNIVERSITY IN UGANDA HEALTH FACILITYen_US
dc.identifier.issn2313-8416
dc.identifier.urihttp://ir.iuiu.ac.ug/xmlui/handle/20.500.12309/784
dc.descriptionThe study, investigated the clinical presentations of patients who tested Positive for Covid-19 (Omicron Variant), their response to treatment, and the levels of transmissibility of the infection. Ien_US
dc.description.abstractThe object of research. The study, investigated the clinical presentations of patients who tested Positive for Covid-19 (Omicron Variant), their response to treatment, and the levels of transmissibility of the infection. Investigated problem. As the globe, continent, and nation are struggling with the emergency of the new COVID-19 omicron Virant outbreak there’s not much information known about the behavior of this new threat to enable clinicians, and public health specialists, and policymakers to curb the problem. The main scientific results. The study found that headache, cough, fevers and, general body weakness was the commonest presenting complaints, 3 of the cases reported difficulties in breathing. None of the cases required admission. There was no difference in the severity of the illness and the response to treatment between the vaccinated and the non-vaccinated cases. Cases that did steaming as an adjuvant/supplementary treatment reported a shorter duration of symptomatic relief than those that did not. The area of practical use of the research results. The findings will act as a practical guide to clinicians, public health specialists, and policymakers in the management of the COVID-19 Omicron Variant. Innovative technological product. The use of steaming as an adjuvant to symptomatic relief management of respiratory tract infections. Scope of the innovative technological product Omicron Variant produces a less severe illness than earlier variants of COVID-19. The study also reveals that vaccination alone was not effective in the prevention of contraction of the Omicron Variant and other newer variants. However, vaccination may have been advantageous in protecting the cases from progressing to severe disease. Thus, other IPCs measures must be maintained and booster doses of COVID-19 vaccinations should be encouraged. Large-scale on the effectiveness of steaming and other locally made remedies for symptomatic management of respiratory tract infections should be donen_US
dc.language.isoenen_US
dc.publisherInnovative technologies in healthcareen_US
dc.relation.ispartofseriesScienceRise;1 (78),
dc.subjectSars-Cov-2 B.1.1.529en_US
dc.subjectOmicronen_US
dc.subjectPresentationsen_US
dc.subjectCharacteristicsen_US
dc.subjectResponse to Treatmenten_US
dc.subjectSteamingen_US
dc.subjectHerbal treatmenten_US
dc.subjectHome-based careen_US
dc.subjectUgandaen_US
dc.titleSARS-COV-2 B.1.1.529 (OMICRON) VARIANT OUTBREAKen_US
dc.title.alternativeCASE SERIES PRESENTATIONS AND RESPONSE TO TREATMENT AT THE ISLAMIC UNIVERSITY IN UGANDA HEALTH FACILITYen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record